BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29505008)

  • 1. Is the ratio superior to the number of metastatic lymph nodes in addressing the response in patients with papillary thyroid cancer?
    Gao W; Zhao T; Liang J; Lin Y
    Medicine (Baltimore); 2018 Jan; 97(3):e9664. PubMed ID: 29505008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PROGNOSTIC VALUE OF LYMPH NODE UPTAKE ON PRETREATMENT F-18 FDG PET/CT IN PATIENTS WITH N1B PAPILLARY THYROID CARCINOMA.
    Lee CH; Lee SW; Son SH; Hong CM; Jeong JH; Jeong SY; Ahn BC; Lee J
    Endocr Pract; 2019 Aug; 25(8):787-793. PubMed ID: 31013158
    [No Abstract]   [Full Text] [Related]  

  • 3. SIZE OF THE LARGEST METASTATIC FOCUS TO THE LYMPH NODE IS ASSOCIATED WITH INCOMPLETE RESPONSE OF PN1 PAPILLARY THYROID CARCINOMA.
    Deng Y; Zhu G; Ouyang W; Pan L; Feng H; Wu J; Chen P; Wang J; Xian J
    Endocr Pract; 2019 Sep; 25(9):887-898. PubMed ID: 31170371
    [No Abstract]   [Full Text] [Related]  

  • 4. Preablative Stimulated Thyroglobulin Levels Can Predict Malignant Potential and Therapeutic Responsiveness of Subcentimeter-Sized, 18F-fluorodeoxyglucose-Avid Cervical Lymph Nodes in Patients With Papillary Thyroid Cancer.
    Kwon SY; Kim J; Jung SH; Chong A; Song HC; Bom HS; Min JJ
    Clin Nucl Med; 2016 Jan; 41(1):e32-8. PubMed ID: 26164179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use superb microvascular imaging to diagnose and predict metastatic cervical lymph nodes in patients with papillary thyroid carcinoma.
    Huang T; Huang PT; Luo ZY; Lv JF; Jin PL; Zhang T; Zhao YL; Wang Y; Hong YR
    J Cancer Res Clin Oncol; 2024 May; 150(5):268. PubMed ID: 38772976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for level V metastasis in patients with N1b papillary thyroid cancer.
    Kang JG; Choi JE; Kang SH
    World J Surg Oncol; 2022 Sep; 20(1):327. PubMed ID: 36180912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum antithyroglobulin antibodies interfere with thyroglobulin detection in fine-needle aspirates of metastatic neck nodes in papillary thyroid carcinoma.
    Jeon MJ; Park JW; Han JM; Yim JH; Song DE; Gong G; Kim TY; Baek JH; Lee JH; Shong YK; Kim WB
    J Clin Endocrinol Metab; 2013 Jan; 98(1):153-60. PubMed ID: 23144473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma.
    Jeon MJ; Yoon JH; Han JM; Yim JH; Hong SJ; Song DE; Ryu JS; Kim TY; Shong YK; Kim WB
    Eur J Endocrinol; 2013 Feb; 168(2):219-25. PubMed ID: 23161752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroglobulin in washout fluid from lymph node fine-needle aspiration biopsy in papillary thyroid cancer: large-scale validation of the cutoff value to determine malignancy and evaluation of discrepant results.
    Moon JH; Kim YI; Lim JA; Choi HS; Cho SW; Kim KW; Park HJ; Paeng JC; Park YJ; Yi KH; Park DJ; Kim SE; Chung JK
    J Clin Endocrinol Metab; 2013 Mar; 98(3):1061-8. PubMed ID: 23393171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of thyroglobulin in the lymph nodes recurrence of papillary thyroid carcinoma undergoing total thyroidectomy.
    Xing Z; Qiu Y; Li Z; Zhang L; Fei Y; Zhu J; Su A
    BMC Surg; 2021 Jan; 21(1):53. PubMed ID: 33482804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shear wave elastography in evaluation of cervical lymph node metastasis of papillary thyroid carcinoma: elasticity index as a prognostic implication.
    Jung WS; Kim JA; Son EJ; Youk JH; Park CS
    Ann Surg Oncol; 2015 Jan; 22(1):111-6. PubMed ID: 24740830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroglobulin level in fine-needle aspirates for preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma: two different cutoff values according to serum thyroglobulin level.
    Jeon MJ; Kim WG; Jang EK; Choi YM; Lee YM; Sung TY; Yoon JH; Chung KW; Hong SJ; Baek JH; Lee JH; Kim TY; Shong YK; Kim WB
    Thyroid; 2015 Apr; 25(4):410-6. PubMed ID: 25607926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Changes in the Clinical Outcome of Papillary Thyroid Carcinoma With Cervical Lymph Node Metastasis.
    Jeon MJ; Kim WG; Choi YM; Kwon H; Song DE; Lee YM; Sung TY; Yoon JH; Hong SJ; Baek JH; Lee JH; Ryu JS; Kim TY; Shong YK; Chung KW; Kim WB
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3470-7. PubMed ID: 26120792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence of papillary thyroid carcinoma with lateral cervical node metastases: Predictive factors and operative management.
    Chéreau N; Buffet C; Trésallet C; Tissier F; Leenhardt L; Menegaux F
    Surgery; 2016 Mar; 159(3):755-62. PubMed ID: 26435440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active Surveillance of Small Metastatic Lymph Nodes as an Alternative to Surgery in Selected Patients with Low-Risk Papillary Thyroid Cancer: A Retrospective Cohort Study.
    Jerkovich F; Abelleira E; Bueno F; Guerrero L; Pitoia F
    Thyroid; 2022 Oct; 32(10):1178-1183. PubMed ID: 35876426
    [No Abstract]   [Full Text] [Related]  

  • 16. UNFAVORABLE RESPONSES TO RADIOIODINE THERAPY IN N1B PAPILLARY THYROID CANCER: A PROPENSITY SCORE MATCHING STUDY.
    Liu YQ; Li H; Liu JR; Lin YS
    Endocr Pract; 2019 Dec; 25(12):1286-1294. PubMed ID: 31412228
    [No Abstract]   [Full Text] [Related]  

  • 17. Lymph node characteristics for predicting locoregional recurrence of papillary thyroid cancer in adolescents and young adults.
    Sun Y; Liu X; Ouyang W; Feng H; Wu J; Chen P; Wang J
    Oral Oncol; 2017 Mar; 66():22-27. PubMed ID: 28249644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroglobulin measurements in fine-needle aspiration cytology of lymph nodes for the detection of metastatic papillary thyroid carcinoma.
    Li QK; Nugent SL; Straseski J; Cooper D; Riedel S; Askin FB; Sokoll LJ
    Cancer Cytopathol; 2013 Aug; 121(8):440-8. PubMed ID: 23495036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of percutaneous ultrasound guided radiofrequency ablation for treating cervical metastatic lymph nodes from papillary thyroid carcinoma.
    Guang Y; Luo Y; Zhang Y; Zhang M; Li N; Zhang Y; Tang J
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1555-1562. PubMed ID: 28342000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors and indication for dissection of right paraesophageal lymph node metastasis in papillary thyroid carcinoma.
    Zhang L; Liu H; Xie Y; Xia Y; Zhang B; Shan G; Li X
    Eur J Surg Oncol; 2016 Jan; 42(1):81-6. PubMed ID: 26615455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.